27 September 2023
Life Sciences
What is the impact of Artificial Intelligence on the Italian National Health System? What are the novelties introduced by the new Ministry of Health Guidelines on the advertising of SOP and OTC to the public? Which services can be provided through 𝘁𝗲𝗹𝗲𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲? How can a 𝘄𝗲𝗮𝗿𝗮𝗯𝗹𝗲 𝗯𝗲 classified 𝗮𝘀 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲? And moreover, how the lifecycle of pharmaceutical products and medical devices is affected by the new system? And what about clinical trials?
Our Stefano Giberti and Erica Benigni guide us through the complex Italian regulation system, providing answers to some of the hottest topics in healthcare and medical devices and highlighting the changes in the policy and legislative reform.
Their contribution, for the second year, is part of the prestigious Medical Device & Consumer Health Products 2023, published by Chambers Global Practice Guides. Full chapater available below.